Literature DB >> 29799955

Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.

Scott E Hadland1,2,3, Magdalena Cerdá4, Yu Li5, Maxwell S Krieger5, Brandon D L Marshall5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29799955      PMCID： PMC6145750          DOI： 10.1001/jamainternmed.2018.1999

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Industry Payments to Physicians for Opioid Products, 2013-2015.

Authors:  Scott E Hadland; Maxwell S Krieger; Brandon D L Marshall
Journal:  Am J Public Health       Date:  2017-09       Impact factor: 9.308

2.  Increased use of heroin as an initiating opioid of abuse.

Authors:  Theodore J Cicero; Matthew S Ellis; Zachary A Kasper
Journal:  Addict Behav       Date:  2017-05-23       Impact factor: 3.913

3.  Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.

Authors:  Colette DeJong; Thomas Aguilar; Chien-Wen Tseng; Grace A Lin; W John Boscardin; R Adams Dudley
Journal:  JAMA Intern Med       Date:  2016-08-01       Impact factor: 21.873

4.  Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.

Authors:  Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-07-07       Impact factor: 17.586
  4 in total
  29 in total

1.  Medical Use of Long-term Extended-release Opioid Analgesics in Commercially Insured Adults in the United States.

Authors:  Jessica C Young; Michele Jonsson Funk; Nabarun Dasgupta
Journal:  Pain Med       Date:  2020-04-01       Impact factor: 3.750

2.  Association of Pharmaceutical Manufacturer Payments to Physicians and Prescribing Dosage of Opioids.

Authors:  William Fleischman; Shantanu Agrawal; Cary P Gross; Joseph S Ross
Journal:  J Gen Intern Med       Date:  2019-07       Impact factor: 5.128

3.  Innovation and safety in critical care: should we collaborate with the industry? Con.

Authors:  Anders Perner; Jon Henrik Laake; Iwan C C van der Horst
Journal:  Intensive Care Med       Date:  2018-11-08       Impact factor: 17.440

4.  Psychiatry and the Opioid Crisis in Canada.

Authors:  Grainne E Neilson; Alison Freeland; Christian G Schütz
Journal:  Can J Psychiatry       Date:  2019-11-18       Impact factor: 4.356

5.  Financial Payments to Teaching Hospitals by Companies Marketing Opioids.

Authors:  Timothy S Anderson; Maxwell S Krieger; Brandon D L Marshall; Magdalena Cerdá; Scott Hadland
Journal:  J Gen Intern Med       Date:  2019-12-17       Impact factor: 5.128

6.  Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty.

Authors:  Mara A G Hollander; Julie M Donohue; Bradley D Stein; Elizabeth E Krans; Marian P Jarlenski
Journal:  J Gen Intern Med       Date:  2019-12-02       Impact factor: 5.128

Review 7.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

8.  The Impact Of Academic Medical Center Policies Restricting Direct-To-Physician Marketing On Opioid Prescribing.

Authors:  Matthew D Eisenberg; Elizabeth M Stone; Harlan Pittell; Emma E McGinty
Journal:  Health Aff (Millwood)       Date:  2020-06       Impact factor: 6.301

9.  An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations.

Authors:  Rosanna Smart; Caroline K Geiger; Christopher M Jones; Bradley D Stein
Journal:  J Gen Intern Med       Date:  2019-10-21       Impact factor: 5.128

10.  Factors That Influence Changes to Existing Chronic Pain Management Plans.

Authors:  Julie Diiulio; Laura G Militello; Barbara T Andraka-Christou; Robert L Cook; Robert W Hurley; Sarah M Downs; Shilo Anders; Burke W Mamlin; Elizabeth C Danielson; Christopher A Harle
Journal:  J Am Board Fam Med       Date:  2020 Jan-Feb       Impact factor: 2.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.